Related Experiment Video
Updated: Jun 26, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
Cell therapy of acute myocardial infarction: open questions
Stefanie Dimmeler1, Andreas M Zeiher
1Molecular Cardiology, Department of Internal Medicine III, University of Frankfurt, Theodor Stern Kai 7, Frankfurt, Germany. dimmeler@em.uni-frankfurt.de
Abstract:
Cell-based therapy is a promising option for treatment of cardiovascular diseases. Based on experimental studies demonstrating that bone marrow-derived stem and progenitor cells improve the functional recovery after ischemia, clinical trials were initiated to address this new therapeutic concept. So far, clinical studies preferentially used adult bone marrow-derived cells for the treatment of patients with acute myocardial infarction. Overall, cell therapy was shown to reduce the infarct size and improve cardiac contractile function. However, the extent of functional improvement varied between the studies and various questions remain. The present review article will discuss the heterogeneity of the clinical results, the timing of the cell delivery and the benefit achieved so far in different patient populations.
More Related Videos
09:11Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
Published on: September 22, 2014
11:51Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
Published on: March 1, 2016
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Myocarditis I: Introduction
Myocarditis III: Medical Management
Cardiomyopathy V: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations